Stock PAOG PAO GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News PAO Group, Inc.

Equities

PAOG

US6986681004

Market Closed - OTC Markets
Other stock markets
 03:40:28 2024-07-15 pm EDT 		5-day change 1st Jan Change
0.0004 USD -20.00% Intraday chart for PAO Group, Inc. 0.00% -20.00%
2022 PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow CI
2022 Puration, Inc. and PAO Group, Inc. To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PAO : PAOG 2022 SECOND QUARTER REPORT AND DISCLOSURE
PU
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow
AQ
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow
CI
PURA Hemp Crypto Carbon Credit and Asian Expansion On Track
AQ
PURA and PAOG On Track To Launch CBD Product Line For $40 Billion Women’s Health Market
AQ
PURA Confirms New CBD Product Line For $40 Billion Women’s Health Market
AQ
PURA and PAOG To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market
AQ
Puration, Inc. and PAO Group, Inc. To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market
CI
PURA Expects To Boost Revenue Entering $17 Billion CBD Nutraceutical Market
AQ
PURA and PAOG Plan Sneak Peek Of CBD Nutraceutical Product Line For $17 Billion Market Opportunity
AQ
CapitalGainsReport: CBD Beverages Expected to Drive Growth in Broader CBD Market (RLBD, KGKG, PURA, PAOG, HIPH)
AQ
PURA and PAOG Plan Joint CBD Nutraceutical Product Line Launch Next Month
AQ
Puration, Inc and PAO Group, Inc Plan Joint Cbd Nutraceutical Product Line Launch Next Month
CI
PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign
GL
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development
GL
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development
GL
PAOG Publishes 2022 Strategic Update
GL
PAOG Publishes 2022 Strategic Update
GL
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development
GL
PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAOG Stock
  4. News PAO Group, Inc.